7-75120963-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001003795.3(GTF2IRD2B):c.311C>T(p.Thr104Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000657 in 152,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001003795.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152222Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.0000866 AC: 17AN: 196298Hom.: 0 AF XY: 0.0000832 AC XY: 9AN XY: 108174
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000903 AC: 132AN: 1461574Hom.: 0 Cov.: 30 AF XY: 0.0000894 AC XY: 65AN XY: 727106
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152222Hom.: 0 Cov.: 28 AF XY: 0.0000538 AC XY: 4AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.311C>T (p.T104M) alteration is located in exon 4 (coding exon 3) of the GTF2IRD2B gene. This alteration results from a C to T substitution at nucleotide position 311, causing the threonine (T) at amino acid position 104 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at